Showing results (2031-2040 of 6,887) with videos related to
Sort By:
Pageof 689
Leukemia Research|February 22, 2011
Numbers and proportions of leukemias in young people and adults induced by radiation of natural originGerald Kendall, Mark P Little, Richard WakefordLeukemia Research|January 29, 2011
Cellular elements of the subarachnoid space promote ALL survival during chemotherapyStephen M Akers, Stephanie L Rellick, James E Fortney, et al.Leukemia Research|February 12, 2011
7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathwayBing Lin, Zhuo Chen, Yufang Xu, et al.Leukemia Research|February 2, 2011
Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapyLilian Amrein, David Davidson, May Shawi, et al.Leukemia Research|February 2, 2011
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2M E D Chamuleau, G J Ossenkoppele, A van Rhenen, et al.Leukemia Research|February 5, 2011
Changes in the activity of the GPx-1 anti-oxidant selenoenzyme in mononuclear cells following imatinib treatmentEmily N Terry, Peter H Gann, Robert Molokie, et al.Leukemia Research|March 1, 2011
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemiaYi Luo, Yanmin Zhao, Yamin Tan, et al.Leukemia Research|February 15, 2011
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapyDhaval R Mehta, Kenneth A Foon, Robert L Redner, et al.Leukemia Research|December 21, 2010
Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemiaJihong Niu, Henan Li, Yao Zhang, et al.Leukemia Research|December 28, 2010
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemiaMargherita Maffioli, Mireia Camós, Anna Gaya, et al.Pageof 689